The Dermatology Life Quality Index ( DLQI ) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review
Journal of the European Academy of Dermatology and Venereology · 2025-03 · 39 (3) · 631-679
DOI: 10.1111/jdv.20321 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 13.09.2024. Verfasst von J Vyas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, UK. Hauptthemen laut MEDLINE: Quality of Life, Skin Diseases, Patient Reported Outcome Measures, Dermatology. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Infection and Immunity, School of Medicine, Cardiff University.
Abstract (Originalsprache)
Background
The validation of psychometric measures requires use of other established and standardized validated measures. The Dermatology Life Quality Index (DLQI) is the most widely used tool to measure the burden of skin diseases and assess effectiveness of interventions based on patients' perspective.
Objectives
The objective of this study was to systematically analyse peer‐reviewed publications describing use of the DLQI in validation of other patient‐reported outcome (PRO) and quality‐of‐life (QoL) measures.
Methods
Seven databases were searched for papers published between January 1994 and December 2022 for articles containing data using DLQI in the validation of other PRO/QoL measures. The methodology followed PRISMA guidelines. The protocol was prospectively registered on PROSPERO.
Results
Of 1717 screened publications, 122 articles including 30,727 patients from 34 different countries with 41 diseases met the inclusion criteria. The DLQI was used in validation of 101 measures: 80 dermatology‐specific QoL measures, mostly disease‐specific, and 21 generic measures. Of these studies, 47 were cross‐cultural adaptations, 116 single arm, 100 were cross‐sectional, 18 longitudinal and six randomized placebo controlled. DLQI was used for 14 known group, and correlation for 10 construct, 101 convergent, 10 concurrent, 10 divergent/discriminant and three criterion validity tests using Mann–Whitney (2), Spearman's (80), Pearson's correlation (26) and Student's t ‐test (1). The DLQI was used in responsiveness analysis in 13 studies.
Conclusions
This review identified widespread use of the DLQI in validation of other dermatology PRO/QoL measures and confirmed the central role that the DLQI plays as a benchmark in instrument development and validation across dermatology and beyond. The use of the DLQI by so many developers of other instruments has provided a common standard for comparability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Medical Education, School of Medicine, Cardiff University, Cardiff, UK.
- Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
- University Hospitals Birmingham, NHS Foundation Trust, Birmingham, UK.
- School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.
ORCID-Profile: J R Johns, A Y Finlay
Förderung
- Division of Infection and Immunity, School of Medicine, Cardiff University
Zitieren
APA
Vyas, J., Johns, J. R., Abdelrazik, Y., Ali, F. M., Ingram, J. R., Salek, S., & Finlay, A. Y. (2025). The Dermatology Life Quality Index ( DLQI ) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology, 39(3), 631-679. https://doi.org/10.1111/jdv.20321
Vancouver
Vyas J, Johns JR, Abdelrazik Y, Ali FM, Ingram JR, Salek S, et al. The Dermatology Life Quality Index ( DLQI ) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology. 2025;39(3):631-679. doi:10.1111/jdv.20321
BibTeX
@article{Vyas2025,
author = {Vyas, J and Johns, J R and Abdelrazik, Y and Ali, F M and Ingram, J R and Salek, S and Finlay, A Y},
title = {The Dermatology Life Quality Index ( DLQI ) used as the benchmark in validation of 101 quality‐of‐life instruments: A systematic review},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {3},
pages = {631--679},
doi = {10.1111/jdv.20321}
}
EUVIMED